3D Bioprinting Market Overview

The 3D bioprinting market is growing pervasively, mainly due to the burgeoning medical implant market. 3D Bioprinting is an emerging technology, which has the potential to transform the medical field with its capacity to bio fabricate living tissues organs by combining a patient's own cells with other biomaterials. Moreover, researchers, innovators, and early adopters are improving the performance of this disruptive technology stepwise, as it grows. the global 3D bioprinting market is projected to accrue a valuation of USD 1,923.02 MN by 2023. In its recently published analysis, MRFR also asserts that the market would register a whopping CAGR of around 15.4% throughout the review period. Currently, the 3D bioprinting is used to print tissues organs and in the drug discovery.

Various factors are propelling the 3D Bioprinting Market growth. These factors, as per the new Market Research Future (MRFR) report, include growing geriatric population, increased research and development investments, technological advancements, growing compliance in drug development and discovery, a limited number of organ donors, and increasing cases of chronic diseases. Additional factors pushing market growth include innovations in 3D bioprinting technologies, growing use in cosmetic surgeries and pharmaceutical industries, increasing grants, funds, and investments for research by public-private organizations and an increasing number of organ transplantation. 

The technology has been already used for successfully performing surgeries such as spinal implants, dental procedures, the formation of 3D ears, etc. Extensive research is being conducted for the diversification of applications of 3D bioprinting. It is expected to facilitate the performance of major surgeries such as heart transplant in the nearby future. This, in turn, is likely to keep the 3D bioprinting market highly attractive over the next couple of years. Increasing demand for prosthetics is poised to catapult the market on upward trajectory. In addition, a rising number of organ failures is another major factor anticipated to motivate the expansion of the 3D bioprinting market in the upcoming years. Rising healthcare expenditures is further projected to support market growth over the next few years.

3D Bioprinting Market Market Segmentation

• Based on the segment, the global 3D bioprinting market has been segmented based on material, end user, technology, and application. 
• By technology, the global 3D bioprinting market has been segmented into inkjet 3D bioprinting, microextrusion bioprinting, magnetic 3D bioprinting, and laser-assisted bioprinting. Among these, microextrusion bioprinting will lead the market during the forecast period for its extensive applications in bioprinting. 
• By material, the global 3D bioprinting market has been segmented into hydrogels, living cells, and extracellular matrices. Among these, living cells will have the largest share in the market during the forecast period. 
• By applications, the market has been segmented into research and clinical applications. Among these, research applications will dominate the market during the forecast period for its extensive application in 3D cell culture and regenerative medicine. 
• By end users, the global 3D bioprintingmarket has been segmented into pharmaceutical biotechnology companies and research organizations academic institutes. Among these, pharmaceutical biotechnology companies will hold the largest share in the market during the forecast period. 

3D Bioprinting Market Market Regional Analysis

By region, the 3D bioprinting market report covers the latest trends and growth opportunities across the Asia Pacific, the Americas, the Middle East, and Africa, and Europe. Of these, the Americas will lead the market over the forecast period. This is chiefly on account of the growing demand for organs among the patient pool, the presence of developed healthcare infrastructure, and increasing investments in RD activities. Moreover, the availability of 3D printed pills that can be customized as per the body weight and age of a person is also boosting the market growth. 

The global 3D bioprinting market in the APAC region is expected to grow at the fastest pace during the forecast period. This is chiefly on account of plenty of opportunities, developments in 3D printing, booming healthcare sector, and government funds for accelerating the 3D printing technology pace. 

The global 3D bioprinting market in Europe is expected to have a healthy growth over the forecast period owing to the growing focus on health and wellness, increasing demand for cosmetic surgery, and agreements amongst key players for expediting the evolution of technology. 

The 3D bioprinting market in the MEA is predicted to have a stable growth over the forecast period. 

3D Bioprinting Market Market Players

• FUJIFILM Wako Automation Corporation (U.S.)
• Nano3D Biosciences Inc. (U.S.)
• Organovo Holdings Inc. (U.S.)
• REGENHU Ltd. (Switzerland),
• Aspect Biosystems Ltd. (Canada)
• Allevi (U.S.)
• Regenovo Biotechnology Co. Ltd. (China)
• EnvisionTEC GmbH (Germany)
• Stratasys Ltd. (U.S.)
• Cyfuse Biomedical K.K. (Japan)
• Poietis (France),
• Cellink AB (Sweden).

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com